More than 1,800 employees at the Bern facility develop and manufacture innovative biotherapies derived from human plasma.
R&D Switzerland at a glance: We are strengthening our local R&D network to contribute to our global strategic goals.
We are proud to work in the field of rare and serious diseases and to provide therapy in many areas of treatment.
We also aim to make sure that nothing holds you back from getting the therapies you need.
We operate as one integrated global R&D organization that assembles coordinated global project teams.
CSL supports Investigator-Initiated Studies (IIS) that advance medical and scientific knowledge of CSL Behring products and the diseases they treat.
Every day at CSL Behring, we work as if someone's life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Popular search terms:
2018
News from CSL Behring
Watch Flora Goepper's video and get to know CSL Behring's diverse team in Lengnau
CSL Behring’s manufacturing site in Bern goes green in a joint project with local water authority
The Augmented Reality app “PlasmiX”, developed by the Bern software company afca. in collaboration with CSL Behring, was awar…
In the middle of the city, 250 million Swiss francs are currently being invested in an expansion project on the CSL Behring s…
Crossing mountains, gorges and lakes to build team unity.
CSL's original site was once home to its founding director, now it has 2,000 workers.
Meeting the needs of rare disease patients includes keeping processes germ free.
Every day takeaways from CSL Behring’s team building adventure in the Rockies.
Get ready to text lab coats, petri dishes, test tubes and more.
Americas
Asia Pacific
Middle East
Europe
